The 36-month beta value for ELAN is at 1.32. Analysts have varying views on the stock, with 4 analysts rating it as a “buy,” 1 rating it as “overweight,” 6 as “hold,” and 0 as “sell.”
The public float for ELAN is 488.17M, and currently, shorts hold a 2.55% of that float. The average trading volume for ELAN on April 16, 2024 was 4.15M shares.
ELAN) stock’s latest price update
The stock of Elanco Animal Health Inc (NYSE: ELAN) has decreased by -3.34 when compared to last closing price of 14.35. Despite this, the company has experienced a -10.40% fall in its stock price over the last five trading sessions. Reuters reported 2024-03-31 that Investment firm Ancora Holdings has reached an agreement with Elanco Animal Health to add two of its director candidates to the company’s board, Bloomberg News reported late on Sunday, citing people with knowledge of the matter.
ELAN’s Market Performance
ELAN’s stock has fallen by -10.40% in the past week, with a monthly drop of -11.94% and a quarterly drop of -10.80%. The volatility ratio for the week is 3.49% while the volatility levels for the last 30 days are 2.55% for Elanco Animal Health Inc The simple moving average for the last 20 days is -11.19% for ELAN stock, with a simple moving average of 7.46% for the last 200 days.
Analysts’ Opinion of ELAN
Many brokerage firms have already submitted their reports for ELAN stocks, with Stifel repeating the rating for ELAN by listing it as a “Buy.” The predicted price for ELAN in the upcoming period, according to Stifel is $20 based on the research report published on January 05, 2024 of the current year 2024.
Jefferies, on the other hand, stated in their research note that they expect to see ELAN reach a price target of $17. The rating they have provided for ELAN stocks is “Buy” according to the report published on December 19th, 2023.
Morgan Stanley gave a rating of “Overweight” to ELAN, setting the target price at $16 in the report published on December 15th of the previous year.
ELAN Trading at -12.41% from the 50-Day Moving Average
After a stumble in the market that brought ELAN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -17.83% of loss for the given period.
Volatility was left at 2.55%, however, over the last 30 days, the volatility rate increased by 3.49%, as shares sank -11.77% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -6.22% lower at present.
During the last 5 trading sessions, ELAN fell by -10.40%, which changed the moving average for the period of 200-days by +39.26% in comparison to the 20-day moving average, which settled at $15.53. In addition, Elanco Animal Health Inc saw -6.91% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ELAN starting from DOYLE WILLIAM F, who purchase 15,000 shares at the price of $16.30 back on Mar 08 ’24. After this action, DOYLE WILLIAM F now owns 61,330 shares of Elanco Animal Health Inc, valued at $244,500 using the latest closing price.
Harrington Michael J, the Director of Elanco Animal Health Inc, purchase 3,100 shares at $16.29 during a trade that took place back on Mar 08 ’24, which means that Harrington Michael J is holding 77,594 shares at $50,494 based on the most recent closing price.
Stock Fundamentals for ELAN
Current profitability levels for the company are sitting at:
- 0.06 for the present operating margin
- 0.56 for the gross margin
The net margin for Elanco Animal Health Inc stands at -0.28. The total capital return value is set at 0.02. Equity return is now at value -18.22, with -8.25 for asset returns.
Based on Elanco Animal Health Inc (ELAN), the company’s capital structure generated 0.48 points at debt to capital in total, while cash flow to debt ratio is standing at 0.05. The debt to equity ratio resting at 0.93. The interest coverage ratio of the stock is 1.02.
Currently, EBITDA for the company is 945.0 million with net debt to EBITDA at 6.52. When we switch over and look at the enterprise to sales, we see a ratio of 2.78. The receivables turnover for the company is 4.37for trailing twelve months and the total asset turnover is 0.31. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.75.
Conclusion
In conclusion, Elanco Animal Health Inc (ELAN) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
